妊娠不影响分化型甲状腺癌肺转移患者的预后
该回顾性研究纳入124例16至35岁、接受手术和放射性碘治疗的分化型甲状腺癌肺转移女性患者,按治疗后是否妊娠分为妊娠组37例与非妊娠组87例。妊娠组5年和10年无进展生存率分别为94.52%和63.22%,非妊娠组为89.82%和58.13%;5年和10年累积总生存率妊娠组为97.30%和85.77%,非妊娠组为93.50%和81.95%(均P>0.05)。结论认为妊娠不影响此类患者预后,非摄碘性肺转移和原发肿瘤需重复切除是妊娠组预后不良的独立预测因素。
要点
- 妊娠未显著影响DTC肺转移患者术后及碘治疗后的无进展生存和总生存。
- 妊娠组5年和10年无进展生存率分别为94.52%和63.22%。
- 非摄碘性肺转移与需重复切除的原发肿瘤是妊娠组预后不良的独立因素。
核心结论
- 妊娠不影响手术后及放射性碘治疗后分化型甲状腺癌肺转移患者的预后。
- 非摄碘性肺转移和原发肿瘤需重复切除是妊娠组预后不良的独立预测因素。
研究设计与样本
- 回顾性分析124例16至35岁因分化型甲状腺癌肺转移接受手术和放射性碘治疗的女性患者记录。
- 按治疗后是否妊娠分为妊娠组37例和非妊娠组87例,不论治疗前是否有妊娠史。
主要发现
- 妊娠组5年和10年无进展生存率分别为94.52%和63.22%,非妊娠组为89.82%和58.13%。
- 妊娠组5年和10年累积总生存率分别为97.30%和85.77%,非妊娠组为93.50%和81.95%,均P>0.05。
- 妊娠组中位随访82个月(25-136个月),非妊娠组68个月(13-133个月)。
关键数值与推荐
- 无进展生存率与总生存率的组间比较均P>0.05。
- 非摄碘性肺转移和原发肿瘤需重复切除为妊娠组无进展生存的独立预测因素。
临床怎么用
- 对有分化型甲状腺癌肺转移的年轻女性,手术后及放射性碘治疗后妊娠或可不被视为预后不良因素。
- 对非摄碘性肺转移或原发肿瘤需重复切除的妊娠患者应加强预后评估与随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Pregnancy-related hormones may stimulate thyroid cancer growth, but whether pregnancy affects the prognoses of patients with lung metastases from differentiated thyroid cancer (DTC-LM) after surgery and radioiodine therapy is unclear. OBJECTIVE: To assess the impact of pregnancy on DTC-LM through the comparison of prognoses between female patients with DTC-LM who did and did not become pregnant after surgery and radioiodine therapy. METHODS: We retrospectively analyzed the records of 124 female patients aged 16 to 35 years who underwent surgery and radioiodine therapy for DTC-LM. These patients were divided into pregnancy group (n = 37) and nonpregnancy group (n = 87) according to whether they became pregnant after surgery and radioiodine therapy, regardless of whether they had a pregnant history before treatment. RESULTS: The 5- and 10-year progression-free survival rates were 94.52% and 63.22% in pregnancy group versus 89.82% and 58.13% in nonpregnancy group. The 5- and 10-year cumulative overall survival rates of pregnancy group were 97.30% and 85.77% versus 93.50% and 81.95% in nonpregnancy group (all P > 0.05). The median time of follow-up in the pregnancy and nonpregnancy groups was 82 months (25-136 months) and 68 months (13-133 months), respectively. Non-radioiodine-avid LM and primary tumors needing repeated resection were independent predictors of poor progression-free survival for patients in pregnancy group. CONCLUSION: Pregnancy does not affect the prognoses of patients with DTC-LM after surgery and radioiodine therapy. Non-radioiodine-avid LM and repeated primary tumor surgeries are independent risk factors for poor prognoses of pregnant patients.
引用
- Xi C, Zhang Q, Song HJ, et al. Pregnancy Does not Affect the Prognoses of Differentiated Thyroid Cancer Patients With Lung Metastases. J Clin Endocrinol Metab. 2021. PMID: 33674860. doi:10.1210/clinem/dgab111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。